Cyclopharm Limited (ASX:CYC)
0.9200
-0.0100 (-1.08%)
Feb 11, 2026, 10:36 AM AEST
Cyclopharm Revenue
Cyclopharm had revenue of 15.42M AUD in the half year ending June 30, 2025, a decrease of -5.33%. This brings the company's revenue in the last twelve months to 30.72M, up 37.62% year-over-year. In the year 2024, Cyclopharm had annual revenue of 27.57M with 4.68% growth.
Revenue (ttm)
30.72M
Revenue Growth
+37.62%
P/S Ratio
3.36
Revenue / Employee
316.71K
Employees
97
Market Cap
103.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.57M | 1.23M | 4.68% |
| Dec 31, 2023 | 26.34M | 1.48M | 5.97% |
| Dec 31, 2022 | 24.85M | 4.86M | 24.30% |
| Dec 31, 2021 | 20.00M | 2.31M | 13.09% |
| Dec 31, 2020 | 17.68M | 668.06K | 3.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Sonic Healthcare | 9.65B |
| Cochlear | 2.34B |
| Pro Medicus | 212.98M |
| Trajan Group Holdings | 166.46M |
| SDI Limited | 110.38M |
| Alterity Therapeutics | 5.44M |
| Arovella Therapeutics | 3.44M |